Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study

Athanassiou, P; Psaltis, D; Georgiadis, A; Katsifis, G; Theodoridou, A; Gazi, S; Sidiropoulos, P; Tektonidou, MG; Bounas, A; Kandyli, A; Vounotrypidis, P; Sakellariou, GT; Vassilopoulos, D; Huang, ZP; Petrikkou, E; Boumpas, D

Petrikkou, E (通讯作者)，MSD Pharmaceut Ind & Commercial SA, Med Affairs, MSD Greece, 63 Agiou Dimitriou St, Athens 17456, Greece.

RHEUMATOLOGY INTERNATIONAL, 2023; 43 (10): 1871

Abstract

The impact of golimumab (GLM) on remission or low disease activity (LDA) was evaluated in patients with moderate-to-severe rheumatoid arthritis (RA), ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索